Related Experiment Video

Updated: Mar 22, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K

Neuroblastoma arginine addiction subverts the anticancer immune response

Carmela De Santo1, Francis Mussai1

  • 1School of Cancer Sciences, University of Birmingham , Birmingham, United Kingdom.

Oncoimmunology
|April 9, 2016
PubMed

Insights

High-risk neuroblastoma impairs T cell immunity by expressing Arginase II, which depletes arginine. This finding offers new targets for immunotherapy in neuroblastoma treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • High-risk neuroblastoma presents a significant therapeutic challenge with poor patient prognosis.
  • Current immunotherapy approaches show promise but require further optimization for clinical efficacy.

Purpose of the Study:

  • To investigate the role of Arginase II in neuroblastoma-mediated immune suppression.
  • To identify novel therapeutic targets for enhancing anti-tumor immunity in neuroblastoma.

Main Methods:

  • Analysis of Arginase II expression in neuroblastoma.
  • Assessment of arginine levels in tumor microenvironment and systemic circulation.
  • Evaluation of T cell function in the presence of neuroblastoma-derived Arginase II.

Main Results:

  • Neuroblastoma was found to express Arginase II.
  • Arginase II expression correlated with depleted local and systemic arginine concentrations.
  • Neuroblastoma-associated Arginase II suppressed both autologous and engineered T cell immunity.

Conclusions:

  • Arginase II is a key mechanism of immune evasion in high-risk neuroblastoma.
  • Targeting Arginase II may represent a viable strategy to restore T cell function and improve immunotherapy outcomes for neuroblastoma.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

10.1K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K